Brand Name | Status | Last Update |
---|---|---|
empliciti | Biologic Licensing Application | 2022-03-22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 3 | — | — | — | 3 |
Smoldering multiple myeloma | D000075122 | — | — | — | 2 | — | — | — | 2 |
Follicular lymphoma | D008224 | — | C82 | 2 | 2 | — | — | — | 2 |
Plasma cell leukemia | D007952 | — | C90.1 | — | 1 | — | — | — | 1 |
Essential thrombocythemia | D013920 | — | D47.3 | — | 1 | — | — | — | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | — | 1 | — | — | — | 1 |
Polycythemia | D011086 | EFO_0005804 | D75.1 | — | 1 | — | — | — | 1 |
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | — | 1 | — | — | — | 1 |
Hematologic neoplasms | D019337 | — | — | — | 1 | — | — | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
Drug common name | Veltuzumab |
INN | veltuzumab |
Description | Veltuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743088 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | BPD4DGQ314 (ChemIDplus, GSRS) |